Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
News|Articles|March 28, 2019
- Pharmaceutical Technology\'s In the Lab eNewsletter-04-03-2019
- Volume 14
- Issue 4
Clinical Water Purification System Gets Digital Update
Author(s)Pharmaceutical Technology Editors
MilliporeSigma added a new cloud-based, remote lab water service and monitoring capability to its Milli-Q CLX 7000 clinical water purification system.
The Milli-Q CLX 7000 clinical water purification system from MilliporeSigma has been updated with a new cloud-based, remote lab water service and monitoring capability. The Milli-Q Connect online service portal provides digital access to water and system data, allowing users to monitor lab performance remotely and securely.
The Milli-Q Connect system turns passive data into active, actionable information that is available remotely. This process streamlines the production of quality reports, which can be produced in minutes, according to the company.
Other benefits include
- Remote access from anywhere at any time to view real-time system information and water quality data.
- Immediate and customized notifications, with remote access and control of the water system available from a secure online portal.
- Remote diagnostics, and potentially repair, available directly through web-based portal.
- Automatic data backup and rapid retrieval via Milli-Q Connect platform simplifies audit preparation and lab accreditation.
“Scientists have come to expect the same instant connectivity in their lab as they experience in their personal lives,” said Jean-Charles Wirth, head of applied solutions at MilliporeSigma, in a company press release. “This Internet-of-Things technology gives our customers accessibility to view real-time system information, customized notifications and rapid online diagnostics, whether they are at the lab or at home.”
Source:
Articles in this issue
over 7 years ago
Ensuring Robust Stability Testing for Product Longevityover 7 years ago
Lonza Strengthens Cell Capabilitiesover 7 years ago
Lilly and ImmuNext Announce Licensing and Research Collaborationover 7 years ago
Dual Impeller Single-Use Bioreactorover 7 years ago
Tosoh Bioscience Introduces New MALS Detector at Pittcon 2019over 7 years ago
New Protein Characterization Technique Unveiled at Pittcon 2019Related to this article
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.